Upadacitinib
CAS 1310726-60-3
In Stock
Upadacitinib
Cat. No. STUB-API-UPADACITINIBCAS 1310726-60-3In Stock
Technical Data
Cat. No.STUB-API-UPADACITINIB
CAS1310726-60-3
Mol. FormulaC17H19F3N6O
Mol. Weight380.374 g/mol
IUPAC(3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
SMILESCC[C@@H]1CN(C[C@@H]1C2=CN=C3N2C4=C(NC=C4)N=C3)C(=O)NCC(F)(F)F
InChIInChI=1S/C17H19F3N6O/c1-2-10-7-25(16(27)24-9-17(18,19)20)8-11(10)13-5-22-14-6-23-15-12(26(13)14)3-4-21-15/h3-6,10-11,21H,2,7-9H2,1H3,(H,24,27)/t10-,11+/m1/s1
InChI KeyWYQFJHHDOKWSHR-MNOVXSKESA-N
Purity—
Description
Overview
Upadacitinib is used to treat certain types of arthritis such as psoriatic arthritis, rheumatoid arthritis, axial spondyloarthritis, polyarticular juvenile idiopathic arthritis- pJIA. It helps decrease pain, tenderness, and swelling in the joints. Upadacitinib is also used to treat a skin condition called atopic dermatitis. It reduces swelling, itching, and redness in the skin
Anant Labs manufacture and furnish high quality Upadacitinib impurities for global markets. Our Upadacitinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
Upadacitinib1310726-60-3ABT-494Upadacitinib anhydrous4RA0KN46E0(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamideDTXSID901027919(3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamideupadacitinibumRefChem:57163
